Historical record - last NADAC effective date: 4/17/2024

Product Information

TOPIRAMATE 100 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.0559 per EA under NDC 62756071113. Its NADAC has been published 547 times since Nov 28, 2013.

FDA first approved this application on Mar 27, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TOPIRAMATE 100 MG TABLET

Topiramate
$0.0559per EA

Strength

100 mg/1

NDC

62756071113

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

4/17/2024

Active Ingredients

TOPIRAMATE

Approval Type

Generic (ANDA)

FDA Application

ANDA090278

FDA Approved

3/27/2009

TE Code

AB

On Market Since

3/27/2009

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for TOPIRAMATE 100 MG TABLET has been published 547 times since Nov 28, 2013, and over the history we have for it it has declined 34.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0559 per EA
All-time high$0.1153 (Nov 12, 2014)
All-time low$0.0559 (Apr 17, 2024)
Median price$0.0725
Average price$0.0743
Largest weekly change-24.4% (Nov 19, 2014)
Weeks tracked547
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

-11.9%

5Y

-18.2%

All

-34.3%

Last surveyed May 15, 2024 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TOPIRAMATE 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE 100 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $0.0559 per EA (NDC 62756071113), effective May 15, 2024.

How has the price of TOPIRAMATE 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for TOPIRAMATE 100 MG TABLET has declined 34.3%. It has been tracked across 547 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for TOPIRAMATE 100 MG TABLET?

Since Nov 28, 2013, the NADAC for TOPIRAMATE 100 MG TABLET has ranged from a low of $0.0559 (Apr 17, 2024) to a high of $0.1153 (Nov 12, 2014), with a median of $0.0725 per EA.

Are there cheaper alternatives to TOPIRAMATE 100 MG TABLET?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOPIRAMATE 100 MG TABLET, is $0.0550 per EA — about 2% below TOPIRAMATE 100 MG TABLET.

Who manufactures TOPIRAMATE 100 MG TABLET?

TOPIRAMATE 100 MG TABLET (NDC 62756071113) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.